Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Other Operating Expenses (2025)

Neuphoria Therapeutics (NEUP) has disclosed Other Operating Expenses for 1 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses changed N/A to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$1.1 million for FY2020, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2025 was $1.2 million at Neuphoria Therapeutics.
  • The five-year high for Other Operating Expenses was $1.2 million in Q4 2025, with the low at $1.2 million in Q4 2025.